Indications and uses
Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes Temporarily relieves these symptoms occuring with a cold: nasal congestion, cough due to minor throat and bronchial irritation
Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes Temporarily relieves these symptoms occuring with a cold: nasal congestion, cough due to minor throat and bronchial irritation
Do not exceed recommended dosage Do not take more than 4 doses in any 24-hour period age dose Adults and children 12 years of age and older 1 teaspoon every 6 hours Children under 12 years of age ask a doctor
Guaifenesin 200mg
Dextromethorphan HBr, USP 30 mg
Phenylephrine HCL, USP 10 mg
Expectorant
Cough suppressant
Nasal decongestant
In case of overdose, get medical help or contact a Poison Control Center right away.
as a health professional before use.
These could be signs of a serious condition.
Do not exceed recommended dosage
Do not take more than 4 doses in any 24-hour period
| age | dose |
| Adults and children 12 years of age and older | 1 teaspoon every 6 hours |
| Children under 12 years of age | ask a doctor |
Artificial grape flavor, citric acid, D&C red #33, FD&C blue #1, glycerin, methyl paraben, propylene glycol, propyl paraben, purified water, sodium citrate, sucralose.
• Store at 15°-30° C (59°-86°F)
Please call (787) 767-3246
NDC 53809-203-01
DOMETUSS-DMX
COUGH SUPPRESSANT/EXPECTORANT/NASAL DECONGESTANT
Alcohol and Sugar
FREE
Grape Flavor
1 Fl. Oz. (30 mL)
Rev: 12/12
Tamper-Evident Disclosure: Do not use if there is evidence of tampering.
LOT#:/EXP.DATE:
Manufactured for:
DOMEL
SAN JUAN, PUERTO RICO 00924
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1364914 | dextromethorphan HBr 30 MG / guaiFENesin 200 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | PSN | 4 |
| 1364914 | dextromethorphan hydrobromide 6 MG/ML / guaifenesin 40 MG/ML / phenylephrine hydrochloride 2 MG/ML Oral Solution | SCD | 4 |
| 1364914 | dextromethorphan hydrobromide 30 MG / guaifenesin 200 MG / phenylephrine hydrochloride 10 MG per 5 ML Oral Solution | SY | 4 |
| Class | Version | Type | Effective |
|---|---|---|---|
| DEXTROMETHORPHAN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| PHENYLEPHRINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53809-203-01 | 2025-05-20 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| 53809-203-04 | 2025-05-20 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| 53809-203-16 | 2025-05-20 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| 53809-203-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| 53809-203-04 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| 53809-203-16 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-9ddf-d83d-e063-dadaa90ab31f | DOMETUSS-DMX |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53809-203-01 | DOMETUSS-DMX | 30 mL in 1 BOTTLE | LIQUID | 30 | 4 | |
| 53809-203-04 | DOMETUSS-DMX | 118 mL in 1 BOTTLE | LIQUID | 118 | 4 | |
| 53809-203-16 | DOMETUSS-DMX | 473 mL in 1 BOTTLE | LIQUID | 473 | 4 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 53809-203-04 | ML - Milliliter | 53809-203 | 9c618a36-4763-4e66-a25a-8af0d3892d4b | 1 | 2016-02-04 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53809-203 | 53809-203-01, 53809-203-04, 53809-203-16 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GUAIFENESIN | 495W7451VQ | ACTIB |
| DEXTROMETHORPHAN HYDROBROMIDE | 9D2RTI9KYH | ACTIB |
| PHENYLEPHRINE HYDROCHLORIDE | 04JA59TNSJ | ACTIM |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| D&C RED NO. 33 | 9DBA0SBB0L | IACT |
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CITRATE, UNSPECIFIED FORM | 1Q73Q2JULR | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| be5556d6-b889-4313-b690-aeabc71d9f74 | 6949e1c6-df1c-451b-a1e2-9199415440f4 | 2024-12-05 | Warnings | be5556d6-b889-4313-b690-aeabc71d9f74 6949e1c6-df1c-451b-a1e2-9199415440f4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.